Patents by Inventor Sabine Furtinger

Sabine Furtinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation comprising a biopharmaceutical drug
    Patent number: 9480743
    Abstract: The present invention is related to a pharmaceutical formulation comprising a biopharmaceutical drug, said composition further comprising at least one mono- or dicarboxylic acid with a backbone of 2-6 C-Atoms, or at least one salt thereof.
    Type: Grant
    Filed: December 28, 2011
    Date of Patent: November 1, 2016
    Assignee: Hexal AG
    Inventors: Martina Danek-Bulius, Britta Deutel, Sabine Fürtinger, Bernt Pragl, Drago Kuzman
  • Stable aqueous G-CSF formulations
    Patent number: 9119789
    Abstract: The invention relates to stable glutamate-buffered G-CSF formulations having a pH of from 3.5 to 4.8. The invention further concerns lyophilisates and powders obtainable from such formulations, and to pharmaceutical kits containing such lyophilisates and powders.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: September 1, 2015
    Assignee: SANDOZ AG
    Inventors: Sabine Fürtinger, Heinrich Matous
  • PHARMACEUTICAL FORMULATION COMPRISING A BIOPHARMACEUTICAL DRUG
    Publication number: 20130336968
    Abstract: The present invention is related to a pharmaceutical formulation comprising a biopharmaceutical drug, said composition further comprising at least one mono- or dicarboxylic acid with a backbone of 2-6 C-Atoms, or at least one salt thereof.
    Type: Application
    Filed: December 28, 2011
    Publication date: December 19, 2013
    Applicant: HEXAL AG
    Inventors: Martina Danek-Bulius, Britta Deutel, Sabine Furtinger, Bernt Pragl, Drago Kuzman
  • STABLE AQUEOUS G-CSF FORMULATIONS
    Publication number: 20100104627
    Abstract: The invention relates to stable glutamate-buffered G-CSF formulations having a pH of from 3.5 to 4.8. The invention further concerns lyophilisates and powders obtainable from such formulations, and to pharmaceutical kits containing such lyophilisates and powders.
    Type: Application
    Filed: April 4, 2008
    Publication date: April 29, 2010
    Inventors: Sabine Fürtinger, Heinrich Matous